Preliminary studies point out conolidine may inhibit specific ion channels, lessening neuronal excitability and limiting suffering alerts. This system is especially related in neuropathic suffering, exactly where abnormal signaling leads to persistent soreness. Moreover, conolidine seems to impact G protein-coupled receptor (GPCR) pathways integral